Taysha Gene Therapies, Inc. (TSHA) Operating income 2020–2025
Taysha Gene Therapies, Inc. (TSHA) annual operating income history from SEC filings — each fiscal year as reported.
-$110.5MFY2025 · since FY2020: -$43.0M → -$110.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$110.5M | -20.8% |
| FY2024 | -$91.5M | -26.3% |
| FY2023 | -$72.4M | +55.4% |
| FY2022 | -$162.4M | +6.2% |
| FY2021 | -$173.3M | -302.9% |
| FY2020 | -$43.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice